Skip to main content
JR Holding SA logo

JR Holding SA — Investor Relations & Filings

Ticker · JRH ISIN · PLJRINV00013 LEI · 259400KSQ8PHW0768Y03 WAR Financial and insurance activities
Open in API
Filings indexed 754 across all filing types
Latest filing 2020-05-21 Transaction in Own Shar…
Country PL Poland
Listing WAR JRH

About JR Holding SA

https://jrh.ai/

JR Holding SA is an alternative investment company that invests in high-growth potential projects and businesses. The company's portfolio is diversified across future-oriented sectors, including AI and digital business, energy transformation, deeptech, the space industry, biotechnology, med-tech, and gaming. It also focuses on sustainability and the circular economy. JR Holding supports its portfolio companies by providing capital, strategic expertise, and access to an extensive business network, aiming to foster long-term value creation and achieve high rates of return on its investments.

Recent filings

Filing Released Lang Actions
Zbycie akcji własnych przez Emitenta - Content (PL)
Transaction in Own Shares Classification · 98% confidence The document text describes transactions involving the company's own shares ('akcji własnych'). Specifically, it details the sale of 200,000 shares and a preliminary agreement to sell another 400,000 shares. This activity directly relates to the company repurchasing or issuing its own stock, which falls under the definition of 'Transaction in Own Shares' (POS). It is not a general capital change (SHA) but a specific transaction involving treasury stock or share buybacks/sales.
2020-05-21 Polish
Rozpoczęcie publikacji raportów miesięcznych - Content (PL)
Regulatory Filings Classification · 95% confidence The document text, written in Polish, announces a decision by the Management Board of JR HOLDING ASI S.A. to start publishing 'raporty miesięczne' (monthly reports) starting June 10, 2020, on the 10th day of every month. This announcement details the *intent* and *schedule* for future regular reporting, rather than containing the actual financial data or being a comprehensive report itself. Since it is an announcement about the publication schedule of regular reports, it fits best under the category for general regulatory announcements or announcements regarding report publication. Given the specific definitions, 'Report Publication Announcement' (RPA) is suitable as it announces the publication of future reports, or 'Regulatory Filings' (RNS) as a general announcement. Since the core action is announcing the *schedule* for future monthly reports, RPA is a strong fit, but RNS is often used for general procedural announcements. However, the text is an announcement *about* future reports, not the report itself. Given the short length and the nature of announcing a new reporting cadence, RNS (Regulatory Filings - general fallback) or RPA (Report Publication Announcement) are candidates. Since it's a formal announcement setting a new reporting standard, RNS is a safe classification for a procedural announcement not covered by other specific codes like ER or IR. I will lean towards RNS as it is a general regulatory announcement about reporting procedures.
2020-05-12 Polish
Podpisanie aneksu do Term Sheet dotyczącego wdrożenia terapii leczenia stwardnienia rozsianego - Content (PL)
Capital/Financing Update Classification · 98% confidence The document is a formal announcement from the Management Board ('Zarząd') of JR HOLDING ASI S.A. It references previous current reports and details the signing of an amendment (aneks nr 2) to a Term Sheet regarding financing for a specific project (stem cell therapy implementation). The core content revolves around extending deadlines for providing financing (5,000,000.00 PLN) and updates on capital contributions already received. This clearly relates to changes in financing arrangements and capital structure commitments, which aligns best with the 'Capital/Financing Update' category.
2020-05-08 Polish
Objęcie akcji GenXone - Content (PL)
M&A Activity Classification · 95% confidence The document text describes a transaction where JR HOLDING subscribed to and acquired a specific number of shares (72,470 Series D shares) in another company, GenXone, for a total subscription price of 500,043.00 PLN. This action involves a change in capital structure and an investment/acquisition activity. This fits the definition of Capital/Financing Update (CAP) or potentially M&A Activity (TAR). Since it is a direct subscription to newly issued shares in a private placement context (implied by the subscription agreement and pricing), it is best classified as a Capital/Financing Update (CAP), which covers fundraising and capital structure changes. It is not a general regulatory announcement (RNS) because it details a specific corporate action.
2020-04-16 Polish
Zmiana nazwy spółki portfelowej - Content (PL)
Share Issue/Capital Change Classification · 99% confidence The document is a short announcement (874 characters) from the Management Board of JR HOLDING S.A. informing about a change in the name (firm) of its portfolio company, Adelante Sp. z o.o., to Ongeno Sp. z o.o., approved at an Extraordinary General Meeting of Shareholders on April 15, 2020. This is a corporate action announcement regarding a portfolio company's structure, which does not fit neatly into standard financial reports (10-K, IR, ER) or specific event announcements (DIV, DIRS, M&A). Since it is a specific corporate update that doesn't match the defined categories like Board/Management Change (MANG) or Capital Change (CAP), and it is not a general regulatory filing fallback (RNS), I must re-evaluate the closest fit. The change of name/firm is a structural change. Given the options, this type of structural update about a subsidiary, especially one related to a project update, is often classified under general regulatory announcements or corporate governance updates. However, none of the codes perfectly capture a portfolio company name change. Since it is a specific, material corporate event announcement that is not a financial report, and it is not about directors, dividends, or capital structure of the parent company directly, the most appropriate fallback is Regulatory Filings (RNS) as it is a required disclosure of a material event, or potentially Governance Information (CGR) if interpreted broadly as corporate structure. Given the nature of Polish regulatory filings (where such changes are often disclosed via 'raport bieżący' - current report), RNS is the safest general regulatory classification for non-standard disclosures. However, if we strictly interpret the definitions, this is a change in the structure/governance of an associated entity. Since it is a specific, non-financial, non-insider, non-meeting related announcement, RNS is the best fit as a general disclosure.
2020-04-15 Polish
Zawarcie porozumienia inwestycyjnego z Medcamp i GenXone w zakresie finansowania badania nad koronawirusem SARS – CoV – 2. - Content (PL)
Capital/Financing Update Classification · 95% confidence The document is a formal announcement by the management board of JR HOLDING regarding the signing of an investment agreement (Porozumienie inwestycyjne) with Medcamp and GenXone on April 6, 2020. The core subject is a strategic collaboration and investment commitment (at least PLN 500,000) by JR HOLDING into GenXone to finance research related to the SARS-CoV-2 coronavirus, leveraging GenXone's status as a laboratory approved for COVID-19 testing. This describes a specific corporate action related to financing and strategic investment in a portfolio company, which aligns best with the 'Capital/Financing Update' category (CAP). The final sentence, 'O objęciu akcji Genxone Emitent poinformuje osobnym raportem bieżącym' (The Issuer will inform about the subscription of Genxone shares in a separate current report), confirms this is an announcement about a planned financing/investment activity, not the final execution report itself, but the primary theme is the financing agreement.
2020-04-06 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.